Browsing by Author "Wares, Joanna R."
Now showing items 1-5 of 5
-
Developing a minimally structured mathematical model of cancer treatment with oncolytic viruses and dendritic cell injections
Gevertz, Jana L.; Wares, Joanna R. (Hindawi, 2018-10-30)Mathematical models of biological systems must strike a balance between being sufficiently complex to capture important biological features, while being simple enough that they remain tractable through analysis or simulation. ... -
Fostering diversity in top-rated pure mathematics graduate programs
Gevertz, Jana L.; Wares, Joanna R. (American Mathematical Society, 2020-02)The lack of a diverse student body continues to be a problem among graduate programs in pure mathematics. This is true despite broad agreement among scholars that a more diverse student body would greatly improve the ... -
Mentoring undergraduate interdisciplinary mathematics research students: junior faculty experiences
Gevertz, Jana L.; Kim, Peter S.; Wares, Joanna R. (Taylor & Francis, 2017)To be successful, junior faculty must properly manage their time in the face of expanding responsibilities. One such responsibility is supervising undergraduate research projects. Student research projects (either single ... -
Predicting the impact of placing an overdose prevention site in Philadelphia: a mathematical modeling approach
Wares, Joanna R.; Dong, Jing; Gevertz, Jana L.; Radunskaya, Ami; Viner, Kendra; Wiebe, Doug; Solomon, Sara (BMC, 2021-10-30)Background: Fatal overdoses from opioid use and substance disorders are increasing at an alarming rate. One proposed harm reduction strategy for reducing overdose fatalities is to place overdose prevention sites—commonly ... -
Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
Gevertz, Jana L.; Wares, Joanna R.; Crivelli, Joseph j.; Yun, Chae-Ok; Kim, Peter S.; Choi, Il-Kyu (American Academy of Mathematical Sciences, 2015-12)Oncolytic viruses (OVs) are used to treat cancer, as they selectively replicate inside of and lyse tumor cells. The efficacy of this process is limited and new OVs are being designed to mediate tumor cell release of cytokines ...